FOXA
50
-7
OKE
31
-24
HST
20
-4
AMP
37
-6
AZO
55
-8
TRIP
16
-13
AMG
41
-8
PFG
28
-11
VMC
45
-8
M
18
-3
LOW
40
-3
DOW
15
-9
HRL
32
-9
ADSK
36
-4
TDC
13
-10
BSX
53
-10
SYF
44
-9
HAS
41
-4
FAST
33
-11
UNH
45
-10
FOXA
50
-7
OKE
31
-24
HST
20
-4
AMP
37
-6
AZO
55
-8
TRIP
16
-13
AMG
41
-8
PFG
28
-11
VMC
45
-8
M
18
-3
LOW
40
-3
DOW
15
-9
HRL
32
-9
ADSK
36
-4
TDC
13
-10
BSX
53
-10
SYF
44
-9
HAS
41
-4
FAST
33
-11
UNH
45
-10
Financhill
Back

Verona Pharma PLC Stock Predictions

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31

VRNA
Verona Pharma PLC

Last Price:
$53.91
Seasonality Move:
-8.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Crowdfunding to IPO: Nasdaq's Next Breakout?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Verona Pharma PLC Stock Forecast

  • Over the next 52 weeks, Verona Pharma PLC has on average historically risen by 77.1% based on the past 7 years of stock performance.
  • Verona Pharma PLC has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
  • Is Verona Pharma PLC Stock Undervalued?
    The current Verona Pharma PLC [VRNA] share price is $53.90. The Score for VRNA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • VRNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Verona Pharma PLC Stock Go Up Next Year?

  • Over the next 52 weeks, Verona Pharma PLC has on average historically risen by 77.1% based on the past 7 years of stock performance.

Verona Pharma PLC Stock Rating

Sell
31
Verona Pharma PLC (VRNA) is a Sell

Is Verona Pharma PLC overpriced?

  • Verona Pharma PLC has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%

Verona Pharma PLC Stock Price History

Is VRNA stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRNA is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
veronapharma.com

52-Week Data

52-Week High:
70.40
52-Week Low:
11.39

Prediction Charts

Market Cap:
4.6B
Price in USD:
53.90
Volume:
2.1M
Beta:
0.20

Technical Analysis

SMA50:
62.16
SMA100:
52.24
SMA200:
39.02
52-Wk Change:
225.88%

Stock Predictions

  • Is Verona Pharma PLC stock public?
    Yes, Verona Pharma PLC is a publicly traded company.
  • What is the Verona Pharma PLC stock quote today?
    The Verona Pharma PLC stock price is 53.90 USD today.
  • How to buy Verona Pharma PLC stock online?
    You can buy Verona Pharma PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-18 66.43 63.55 66.56 62.95
Mar-19 63.00 66.09 66.42 63.00
Mar-20 65.78 66.27 67.38 65.03
Mar-21 65.87 66.81 66.91 65.48
Mar-24 65.51 66.78 67.31 63.79
Mar-25 66.32 66.18 66.71 65.52
Mar-26 66.01 64.18 66.35 63.93
Mar-27 63.68 64.51 66.81 63.54
Mar-28 64.22 62.70 64.41 62.00
Mar-31 61.50 63.49 63.57 59.40
Apr-1 63.50 58.54 63.75 58.40
Apr-2 57.00 60.29 61.01 55.37
Apr-3 57.42 58.09 59.25 56.71
Apr-4 55.38 53.90 56.48 52.93

Verona Pharma PLC Earnings

Verona Pharma PLC Earnings Report: Per Share Verona Pharma PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.

Verona Pharma PLC Forecast Revenue Growth

Verona Pharma PLC Stock Analysis: Historical quarterly revenues per share for Verona Pharma PLC and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.03 per share, an increase this year of $1.45 per share, and an increase next year of $0.25 per share.

* Verona Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.